menu toggle
As we continue to evolve our brand to Cencora, you will continue to see visual changes. We will be sunsetting amerisourcebergen.com over time and are actively moving content and information over to cencora.com. Please visit cencora.com if you can't find what you are looking for here.

Data Analytics Enables Program Improvements for Faster Access to Therapy

By AmerisourceBergen

Benefits verification (BV) is built into the framework for physician-administered specialty therapies for good reason: it provides patients with both access to leading-edge care and clarity around out-of-pocket costs.

Establishing comprehensive BV protocols helps align providers, payers, and specialty pharmacies at every point along the therapeutic journey. But redundancies can bog down the process, leading to unnecessary delays that affect every stakeholder in the supply chain—particularly patients. Data can reveal a lot about the health of your patient services. But can it tell you when your SP processes create access barriers? 

Read how one manufacturer partnered with Lash Group to leverage data and analytics to find and fix SP fulfillment delays.